Oral melphalan, prednisone,thalidomide versus oral melphalan, prednisone in elderly newly diagnosed myeloma patients

被引：0
|
作者：
Palumbo, A.
Bringhen, S.
Caravita, T.
Falcone, A.
Callea, V.
Cangialosi, C.
Grasso, M.
Galli, M.
Rossini, F.
Catalano, L.
Montanaro, M.
De Stefano, V.
Magarotto, V.
Avonto, I.
Musto, P.
Liberati, A. M.
Cavo, M.
Boccadoro, M.
机构：
[1] Az Osp S Giovanni Battista, Turin, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
[3] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[4] Osped Riuniti Reggio Calabria, Reggio Di Calabria, Italy
[5] Az Osp Cervello, Palermo, Italy
[6] Az Osp S Croce & Carle, Cuneo, Italy
[7] Osped San Gerardo, Monza, Italy
[8] Univ Naples Federico II, Naples, Italy
[9] Osped S Anna, Ronciglione, Italy
[10] Univ Cattolica, Rome, Italy
[11] Ctr Riferimento Oncol Basilicata, Rionero In Vulture, Italy
[12] Monteluce Policlin, Perugia, Italy
[13] Univ Bologna, Ist Seragnoli, Bologna, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0401
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [31] Lenalidomide - prednisone induction followed by lenalidomide - melphalan - prednisone consolidation and lenalidomide - prednisone maintenance in newly diagnosed elderly unfit myeloma patients
    Falco, P.
    Cavallo, F.
    Larocca, A.
    Rossi, D.
    Guglielmelli, T.
    Rocci, A.
    Grasso, M.
    Siez, M. L. M.
    De Paoli, L.
    Oliva, S.
    Molica, S.
    Mina, R.
    Gay, F.
    Benevolo, G.
    Musto, P.
    Omede, P.
    Freilone, R.
    Bringhen, S.
    Carella, A. M.
    Gaidano, G.
    Boccadoro, M.
    Palumbo, A.
    LEUKEMIA, 2013, 27 (03) : 695 - 701
  • [32] Oral melphalan, prednisoneand lenalidomide for elderly newly diagnosed myeloma patients
    Palumbo, A.
    Falco, P.
    Corradini, P.
    Crippa, C.
    Di Raimondo, F.
    Falcone, A.
    Nicola, N.
    Canepa, L.
    Gozzetti, A.
    Morabito, F.
    Knight, R.
    Zeldis, J. B.
    Boccadoro, M.
    Petrucci, M. T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 148 - 148
  • [33] Lenalidomide−prednisone induction followed by lenalidomide−melphalan−prednisone consolidation and lenalidomide−prednisone maintenance in newly diagnosed elderly unfit myeloma patients
    P Falco
    F Cavallo
    A Larocca
    D Rossi
    T Guglielmelli
    A Rocci
    M Grasso
    M L M Siez
    L De Paoli
    S Oliva
    S Molica
    R Mina
    F Gay
    G Benevolo
    P Musto
    P Omedè
    R Freilone
    S Bringhen
    A M Carella
    G Gaidano
    M Boccadoro
    A Palumbo
    Leukemia, 2013, 27 : 695 - 701
  • [34] Melphalan, prednisone, thalidomide and defibrotide in advanced myeloma
    Palumbo, A.
    Gay, F.
    Rus, C.
    Pregno, P.
    Larocca, A.
    Bringhen, S.
    Magarotto, V.
    D'Agostino, F.
    Iacobelli, M.
    Gaidano, G.
    Mitsiades, C.
    Richardson, P. G.
    Anderson, K. C.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 169 - 169
  • [35] E1A06: A phase III trial comparing melphalan, prednisone, and thalidomide (MPT) versus melphalan, prednisone, and lenalidomide (MPR) in newly diagnosed multiple myeloma (MM).
    Stewart, A. Keith
    Jacobus, Susanna J.
    Fonseca, Rafael
    Weiss, Matthias
    Callander, Natalie Scott
    Chanan-Khan, Asher Alban Akmal
    Rajkumar, Vincent
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] E1A06: A PHASE III TRIAL COMPARING MELPHALAN, PREDNISONE, AND THALIDOMIDE (MPT) VERSUS MELPHALAN, PREDNISONE, AND LENALIDOMIDE (MPR) IN NEWLY DIAGNOSED MULTIPLE MYELOMA MM)
    Stewart, A. K.
    Jacobus, S.
    Fonseca, R.
    Weiss, M.
    Callander, N. S.
    Chanan-Khan, A. A.
    Rajkumar, S. V.
    HAEMATOLOGICA, 2014, 99 : 220 - 220
  • [37] Oral lenalidomide plus melphalan and prednisone (R-MP) for newly diagnosed multiple myeloma.
    Palumbo, A.
    Falco, P.
    Benevolo, G.
    Canepa, L.
    D'Ardia, S.
    Gozzetti, A.
    Nozza, A.
    Zeldis, J.
    Boccadoro, M.
    Petrucci, M. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 426S - 426S
  • [38] Oral Revlimid® plus melphalan and prednisone (R-MP) for newly diagnosed multiple myeloma.
    Palumbo, A
    Falco, P
    Musto, P
    Corradini, P
    Di Raimondo, F
    Rossi, G
    Giuliani, N
    Morabito, F
    Luraschi, A
    Falcone, A
    Omedè, P
    Gay, F
    Avonto, I
    Ambrosini, MT
    Bringhen, S
    Zeldis, J
    Knight, R
    Boccadoro, M
    Petrucci, MT
    BLOOD, 2005, 106 (11) : 231A - 232A
  • [39] Bortezomib (Velcade)/Melphalan/Prednisone (VMP) Versus Velcade/Thalidomide/Prednisone (VTP) in Elderly
    Mateos, M. V.
    Martin, M. L.
    Gonzalez, Y.
    Lahuerta, J. J.
    Blade, J.
    Oriol, A.
    Martinez, J.
    Cibeira, M. T.
    de Paz, R.
    Terol, M. J.
    Garcia, J.
    Bengoechea, E.
    Martinez, R.
    Martin, A.
    de Arriba, F.
    Palomera, L.
    Hernandez, J. M.
    Bello, J. L.
    San Miguel, J.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S25 - S25
  • [40] Overall Survival Benefit for Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance with Bortezomib-Thalidomide (VMPT-VT) Versus Bortezomib-Melphalan-Prednisone (VMP) in Newly Diagnosed Multiple Myeloma Patients
    Palumbo, Antonio
    Bringhen, Sara
    Rossi, Dmide
    Cavalli, Maide
    Ria, Roberto
    Gentilini, Silvia
    Patriarca, Francesca
    Nozzoli, Chiara
    Levi, Anna
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Vincelli, Donatella
    Baldini, Luca
    Morabito, Fortunato
    Grasso, Mariella
    Marasca, Roberto
    Rizzo, Manuela
    Pautasso, Chiara
    Falcone, Antonietta Pia
    Gottardi, Daniela
    Montefusco, Vittorio
    Musolino, Caterina
    Cangialosi, Clotilde
    Mansueto, Giovanna
    Liberati, Anna Marina
    Magarotto, Valeria
    Omede, Paola
    Musto, Pellegrino
    Petrucci, Maria Teresa
    Boccadoro, Mario
    BLOOD, 2012, 120 (21)
12345